Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Array Biopharma Inc (NASDAQ:ARRY)

10.56
Delayed Data
As of Feb 24
 +0.20 / +1.93%
Today’s Change
2.44
Today|||52-Week Range
13.40
+20.14%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Revenue and IncomeNet Revenues43.0M43.2M39.3M44.5M
 
 
 
 
 
Cost of Goods Sold5.4M5.2M8.4M8.5M
 
 
 
 
 
Depreciation And Amortization419.0K251.0K475.0K496.0K
 
 
 
 
 
 
Operating ExpensesGross Income37.2M37.8M30.4M35.5M
 
 
 
 
 
General Expenses57.2M60.1M54.4M55.3M
 
 
 
 
 
Research And Development48.8M49.5M46.6M46.5M
 
 
 
 
 
Total Operating Expenses63.1M65.5M63.3M64.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-20.0M-22.3M-24.0M-19.8M
 
 
 
 
 
Extraordinary Charge0.000.00-1.7M-600.0K
 
 
 
Interest Expense On Debt2.7M2.8M3.0M3.1M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-22.7M-25.0M-28.6M-23.3M
 
 
 
 
 
Net Income-22.7M-25.0M-28.6M-23.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS143.3M143.5M145.1M168.1M
 
 
 
 
 
Shares To Calculate EPS Diluted143.3M143.5M145.1M168.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.16-$0.17-$0.20-$0.14
 
 
 
 
 
EPS Diluted-$0.16-$0.17-$0.20-$0.14